Could this powerhouse tech stock be poised for greater gains?
The biotech agricultural giant racks up yet another patent triumph.
Given the Dow's recent highs, many investors are rightly concerned about the inflation of equity prices.
Matt Koppenheffer, was one of the many who attended Berkshire Hathaway's annual meeting last week. His unique and Foolish perspective of the event is a must for serious investors.
An American Society of Clinical Oncology abstract demonstrates a potentially positive long-term side effect of statin use.
Big declines in subscription gamers spells trouble for Activision Blizzard.
Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?
"Iron Man 3" passes $1 billion at the global box office.
It's interesting to look at stocks with low share prices, although they can be misleading.
Learning from the market's past to understand its present.
With foreign currencies declining, what impact will they have on investors?
Is your money sitting around in these three dividend stocks, when it could be working harder for you?
The medical-device maker reports earnings on Tuesday.
You're unique... and your retirement planning should be, too.
Its so boring and mundane that it might just help.
If Yahoo! is buying Tumblr, it won't be contested by Facebook or Microsoft.
Will Yahoo acquire Tumblr to tie together all of its recent acquisitions with a social network?
Can our nation cut its carbon addiction?
Understanding climate change in the investment context largely involves adjusting risk assessments, but there are also many opportunities to invest in solution providers.
Stock Advisor Analyst Jason Moser pulls back the curtain on The Motley Fool's flagship stock-picking service.